The Centers for Medicare and Medicaid Services on Aug. 4 released a toolkit to help states protect children with autism from inappropriate Applied Behavior Analysis treatment and strengthen Medicaid program integrity for one of the fastest-growing service categories in the program.
ABA therapy has been the subject of growing bipartisan scrutiny over documented cases of overuse, fraudulent billing and patient harm. CMS is the single largest payer for ABA services in the United States, making the agency’s guidance a significant step toward imposing guardrails on the sector.
The toolkit provides state Medicaid agencies with guidance on coverage standards, medical necessity criteria and fraud detection methods. States administer their own Medicaid programs within federal guidelines, so CMS toolkits serve as operational blueprints for state-level action.
ABA therapy is a behavioral intervention used to treat autism spectrum disorder. While evidence supports its effectiveness when properly administered, the rapid growth of the ABA industry has attracted providers focused more on billing volume than clinical outcomes, according to federal oversight reports.
Medicaid spending on ABA services has grown into a multi-billion-dollar annual expenditure, driven by expanded state mandates and increased autism diagnosis rates. The growth has outpaced the development of quality standards and oversight mechanisms.
The toolkit addresses concerns from families, clinicians and fraud investigators who have documented cases where children received excessive hours of therapy, were subjected to inappropriate interventions or were enrolled in services without proper clinical justification.